Celltrio
PrivateLast Round
Early Funding
Jun 17, 2025
Total Funding Raised
$15M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Celltrio operates in Healthcare & Life Sciences and is based in Fremont, California. Its latest recorded funding round was an Early Funding round in June 2025.
Celltrio is a biotechnology company that develops and manufactures robotic-based solutions and modular lab automation systems for the life sciences industry.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Industrial Robotics, Workflow Automation, Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Celltrio Comparables
Compare Celltrio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Multiply Labs | 87% | |
| Cellular Origins | 85% | |
| Ori Biotech | 80% |
For institutional investors. Book with your work email.
Celltrio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Celltrio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asia2G Capital | Early Funding |
| Premier Partners | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2026
Grew 19% QoQ, from 31 to 37 employees.
- Jun 19, 2026
Monthly visitors grew 184% MoM, reaching 3K.
For institutional investors. Book with your work email.
Celltrio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Celltrio's valuation, stock price, and market status.
Is Celltrio a public or private company?
Celltrio is a private company.
What is the current stock price of Celltrio?
Celltrio is a private company, so its shares have no public market price. Caplight tracks Celltrio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Celltrio worth (valuation)?
Valuation information for Celltrio is not publicly available.
Can I buy Celltrio stock?
Celltrio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Celltrio's last funding round?
Celltrio's most recent funding round was Early Funding on June 17, 2025.
Who are the main investors in Celltrio?
Key investors in Celltrio include Premier Partners.
Will Celltrio IPO soon?
No public IPO plans have been announced for Celltrio.
How can I track Celltrio secondary market activity?
Caplight tracks bids, offers, and trades in Celltrio's shares on secondary markets.